Description
Description: Lortinib tablets contain the active ingredient Erlotinib, available in a strength of 100 mg per tablet. Manufactured by RPG Life Sciences Ltd., Lortinib is a medication primarily used in the treatment of certain types of cancer. Each pack of Lortinib contains 10 tablets and is intended for oral administration.
Medical Uses: Lortinib (Erlotinib) is indicated for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It belongs to a class of medications known as tyrosine kinase inhibitors (TKIs), which work by blocking the activity of the epidermal growth factor receptor (EGFR), a protein involved in the growth and spread of cancer cells. By inhibiting EGFR signaling, Erlotinib helps slow down or stop the progression of cancer and may improve overall survival in patients with advanced or metastatic disease.
Administration: Lortinib tablets are taken orally, typically once daily, with or without food, as directed by a healthcare professional. The dosage may vary depending on factors such as the type and stage of cancer, overall health, and response to treatment. Patients should swallow the tablets whole with a full glass of water and avoid crushing, chewing, or breaking them before swallowing.
Manufacturer: Lortinib tablets are manufactured by RPG Life Sciences Ltd., a reputable pharmaceutical company known for producing high-quality medications. RPG Life Sciences Ltd. adheres to strict manufacturing standards to ensure the safety, efficacy, and reliability of their products.
Storage: Lortinib tablets should be stored at room temperature (between 20°C and 25°C) in a dry place away from direct sunlight and moisture. It is essential to keep the medication out of reach of children and pets. Patients should not use Lortinib tablets beyond their expiration date.
Precautions:
- Lortinib should only be used under the supervision of a qualified oncologist or healthcare professional experienced in the treatment of cancer.
- Patients should undergo regular monitoring of liver function tests and blood counts during treatment with Lortinib.
- Erlotinib may interact with other medications, so patients should inform their healthcare provider about all current medications, including prescription drugs, over-the-counter medications, and supplements.
Side Effects: Common side effects of Lortinib may include:
- Rash or skin irritation
- Diarrhea
- Fatigue
- Nausea and vomiting
- Loss of appetite
- Dry skin or itching
- Eye irritation or blurred vision
Serious side effects such as liver toxicity, interstitial lung disease, and gastrointestinal perforation may occur but are less common. Patients should seek medical attention if they experience any severe or persistent side effects while taking Lortinib.
Disclaimer: Lortinib tablets should only be used under the supervision of a qualified healthcare professional and as part of a comprehensive treatment plan for cancer. This description provides general information about the medication and its uses and should not replace medical advice from a healthcare provider.
Reviews
There are no reviews yet.